StockClub
OPHLYOno Pharmaceutical Co., Ltd.$ --
Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd.

OPHLY

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 03/31/2025

Revenue

attach_money
486,871M JPY
YoY -3.1%

Operating Income

bar_chart
59,747M JPY
YoY -63.4%

Net Income

verified
50,047M JPY
YoY -60.9%

EPS

pie_chart
35.52JPY
YoY -60.0%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress97%On Track
Revenue Progress401.8B
Revenue Forecast516.2B
Net Income Progress69.9B
Net Income Forecast72.1B

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
486,871
147,950
338,921
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
149,866
30,651
122,219
427,124
59,747
Interest expense
Income before tax
Income tax expense
Net income
5,318
59,328
9,163
50,047

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.